Jen Monnier is an intern at Spectrum. She is a journalist in New York City, covering medicine, technology and ecosystems. She’s also a graduate student at New York University’s Science, Health and Environmental Reporting program.
Jen Monnier
From this contributor
Early interventions, explained
The accepted wisdom in autism research holds that early intervention offers the best promise for an autistic child’s well-being. But how effective are these therapies?
Multipart device monitors various senses in babies
A new assemblage of tools precisely gauges a baby’s biological response to sights, sounds and tactile stimuli all at once.
Multipart device monitors various senses in babies
By
Jen Monnier
17 August 2018 | 2 min read
New consortium may create projects, funding for autism research
A newly formed group of leaders from the U.S. National Institutes of Health (NIH) is poised to generate funding opportunities for child health research, including autism science.
New consortium may create projects, funding for autism research
By
Jen Monnier
2 August 2018 | 3 min read
Glowing capsule illuminates problems in gut
An ingestible electronic capsule enables researchers to instantaneously detect molecules associated with gastrointestinal issues.
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
By
Helena Kudiabor
15 April 2026 | 4 min read